Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
928.85
-7.50
(-0.80%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Cadila Healthcare board to consider the unaudited financial results
>>
Cadila Healthcare informs about Cut-off Date for E-voting
>>
Cadila Healthcare informs about Press Release
>>
Zydus group gets market authorization from USFDA to market Morphine Tablets
>>
Cadila Healthcare informs about copy of Press Release
>>
Zydus Cadila receives USFDA approval to market Pyridostigmine Bromide Tablets
>>
Cadila Healthcare to acquire Claris Lifesciences’ injectables business: Reports
>>
Zydus Cadila to present new clinical data on Lipagyln at AACE, USA
>>
Cadila Healthcare informs about Press Release
>>
Cadila Healthcare gains on announcing a collaborative program with the National Institute of Allergy and Infectious Diseases
<<
<
154
155
156
...168
>
>>